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Abstract
Background: The importance of access to healthcare for all is internationally recognised as a global goal, high on
the global agenda. Yet inequalities in health exist within and between countries which are exacerbated by
inequalities in access to healthcare. In order to address these inequalities, we need to better understand what
drives them. While there exists a wealth of research on access to healthcare in different countries and contexts, and
for different patient groups, to date no attempt has been made to bring this evidence together through a global
lens. This study aims to address that gap by bringing together evidence of what factors affect patients’ access to
healthcare and exploring how those factors vary in different countries and contexts around the world.
Methods: An overview of reviews will be conducted using a comprehensive search strategy to search four
databases: Medline, Embase, Global Health and Cochrane Systematic Reviews. Additional searches will be
conducted on the Gates Foundation, the World Health Organisation (WHO) and World Bank websites. Titles and
abstracts will be screened against the eligibility criteria and full-text articles will be obtained for all records that
meet the inclusion criteria or where there is uncertainty around eligibility. A data extraction table will be developed
during the review process and will be piloted and refined before full data extraction commences. Methodological
quality/risk of bias will be assessed for each included study using the AMSTAR 2 tool. The quality assessment will be
used to inform the narrative synthesis, but a low-quality score will not necessarily lead to study exclusion.
Discussion: Factors affecting patients’ ability to access healthcare will be identified and analysed according to
different country and context characteristics to shed light on the importance of different factors in different
settings. Results will be interpreted accounting for the usual challenges associated with conducting such reviews.
The results may guide future research in this area and contribute to priority setting for development initiatives
aimed at ensuring equitable access to healthcare for all.
Systematic review registration: PROSPERO CRD42019144775
Keywords: Systematic review of systematic reviews, Overview, Access to healthcare, Inequalities in access to
healthcare
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Background
The Universal Healthcare Movement and Sustainable
Development Goals (especially SDG3 ‘Good health and
wellbeing’ and SDG10 ‘reduced inequalities’) demon-
strate the importance of access to healthcare for all as a
global goal, high on the global agenda [1]. Yet inequal-
ities in health persist between and within countries
which are exacerbated by inequalities in patients’ ability
to access healthcare [2–4]. In order to address these
inequalities and move towards these global goals that
encourage fair access to safe, affordable healthcare, we
need to better understand what drives these inequalities
within and between countries.
The importance of access to healthcare is not a new
topic and there is a wealth of research from different
countries and contexts, and relating to a range of patient
groups. However, to date, there has been no attempt to
bring this information together, through a global lens, to
examine the variations in factors that affect patients’
ability to access healthcare depending on the country,
context and related cultural and social characteristics.
This represents a missed opportunity to develop shared
learning about what has and has not worked to improve
access to healthcare. For example, shared learning on suc-
cesses and failures could help systems with poor access to
healthcare to learn from systems that have improved ac-
cess, perhaps despite the low resource base (or other con-
textual factors) they may have in common. This study
aims to address that gap by bringing together evidence of
what factors affect patients’ access to healthcare and ex-
ploring how those factors vary and also what is common
across countries and contexts around the world.
Access to healthcare has several dimensions [5]. Service
availability is one dimension which is concerned with the
supply of healthcare, i.e. the availability of healthcare pro-
fessionals and medicines. While service availability is im-
portant to enable access, just because services are available
it does not necessarily follow that they are accessible and
there are a range of factors that can restrict access. These
are often demand-side (related to the patient) or organisa-
tional factors. These supply- and demand-side factors are
the main focus of this review.
Research question
What factors affect patients’ access to healthcare and
how do they vary in different countries and contexts
around the world?
Aim, design and setting
This study aims to identify what factors act as facilitators
or barriers to patients’ ability to access healthcare, to
develop understanding of what are the most important
factors in different countries and contexts, and to exam-
ine the variation in these factors and the magnitude of
their impact. As such, the review is not limited to one
particular setting, but instead aims to consider the evi-
dence from a global perspective to identify trends that
may be useful to healthcare and development practi-
tioners as they consider what are the best strategies and
areas to target in order to move towards the global goals.
Given the global perspective required to answer this re-
search question, the size of the body of primary evidence
is too large to be manageable in a conventional review.
In addition, much of the primary evidence has already
been compiled within systematic reviews which examine
factors affecting access to healthcare within a limited
region and/or within a particular clinical area. Conse-
quently, this study has been designed as an overview of
systematic reviews in order to answer the research question
in a practical and manageable way [6].
Methods/design
Protocol and registration
This protocol is being reported in accordance with the
PRISMA-P statement [7, 8] (see PRISMA-P checklist in
Additional file 1). This overview protocol was registered
with the International Prospective Register of Systematic Re-
views (PROSPERO), registration number CRD42019144775.
Eligibility criteria
Inclusion and exclusion criteria are summarised in Table 1.
Studies will be selected for inclusion in the review based
on the following criteria.
Type of study. Only systematic reviews will be included
in this review, all other study designs will be excluded. For
the purposes of this review, we define a systematic review
as a review in which systematic searches are conducted in
at least 2 sources, at least 1 being an electronic database,
and in which systematic methods are used for data extrac-
tion and synthesis. This is intentionally a fairly broad and
inclusive definition as we anticipate that a more stringent
definition would lead to the exclusion of research that al-
though may not be of the finest, Cochrane style, quality,
can still provide useful evidence for our research question.
Overviews of systematic reviews will be excluded as al-
though this is a specific type of systematic review, the re-
views they include tend to be more dated and, in addition,
the primary data has already been through two levels of
aggregation meaning the level of detail and nuances in the
data are likely to be reduced.
Subject of the study. To be included in this review ac-
cess to healthcare must be the main focus of the study
and barriers and facilitators to healthcare access must be
identified as an outcome of interest. Given the purpose
of this review is to identify factors affecting access to
healthcare and the variations in those factors in different
settings, it is not possible to say what factors will be rele-
vant or should be prioritised a priori. We will collect
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data on all factors reported to affect access to healthcare
as presented in included articles. However, for the pur-
poses of clarity for the reader, we might expect some
barriers or facilitators to include social or cultural influ-
ences on the decision to seek healthcare, influences on
the ability to travel to a place where healthcare can be
provided or availability of appropriate care. In other
words, studies that identify demand-side (patient factors)
or supply-side (healthcare provider factors) barriers/fa-
cilitators to healthcare access can be included. Studies
which focus on only one barrier, facilitator or interven-
tion affecting access to healthcare will be excluded as
these studies fail to give a complete overview of the fac-
tors affecting patients in their study setting. In addition,
studies that focus on ways to reduce utilization of
healthcare (rather than improve access) will be ex-
cluded. This type of study tends to focus on minimally
regulated healthcare markets (like USA) and are aimed
at reducing access to unnecessary care rather than in-
creasing access of care that is needed—i.e. the purpose
of this type of study is not relevant to the research
question for this overview.
Types of intervention. The focus of this review is ac-
cess to healthcare. A range of interventions or services
can be deemed healthcare and consequently studies
which focus on any intervention or service which is a
means of providing healthcare to living humans is an ac-
ceptable for inclusion in this review.
Types of participants. Reviews based on any disease or
condition affecting living humans can be included.
Types of publication. Published, peer reviewed articles
or non-peer reviewed reports published through
the Gates Foundation, WHO or World Bank websites and
written in English can be included. Conference proceed-
ings, protocol papers, and any publication for which suffi-
cient details to determine eligibility cannot be obtained
will be excluded. Due to resource constraints to conduct
this research, it is not possible to include articles written
in any language other than English. Unpublished reviews
will not be included due to the practical difficulties in ac-
quiring the necessary data for these studies.
Time frame. Only articles published in the last 5 years
will be included. This restriction links to the overview
design of the review. This overview aims to present
Table 1 Inclusion and exclusion criteria
Include Exclude
Type of study
Systematic reviews. Defined for inclusivity as a review in which
systematic searches are conducted in at least 2 sources, at least
1 being an electronic database, and in which systematic methods
are used for data extraction and synthesis.
Any study that is not a systematic review as per the definition opposite.
Overviews (systematic reviews of systematic reviews), as the reviews they
include tend to be more dated. However, reference lists will be reviewed
to ensure eligible reviews they identify are included.
Subject of study
Studies for which access to healthcare is the main focus. Studies for which access to healthcare is not the main focus.
Systematic reviews for which barriers/facilitators to healthcare
access are identified as an outcome of interest.
Studies which discuss barriers/facilitators to access only in the context of
the topic but not as an outcome of the review.
Studies which do not identify barriers or facilitators to accessing healthcare
as an outcome of interest
Studies that identify demand-side (patient factors) or supply-side
(healthcare provider factors) barriers/facilitators to healthcare access.
Studies that present barriers/facilitators to the implementation of a specific
intervention without any focus on how that affects access to healthcare.
Systematic reviews which focus on only one barrier, facilitator or
intervention affecting access to healthcare.
Studies where barriers/facilitators to utilization are identified from the
review (in this case utilization may be a proxy measure for access).
Studies that focus on ways to reduce utilization of healthcare
(rather than improve access).
Types of intervention
Any intervention or service which is a means of providing healthcare
to living humans.
Interventions relating to post-mortem activities.
Types of participants
Reviews based on any disease or condition affecting living humans. Animal studies or post-mortem studies.
Type of publication
Published, peer reviewed articles or non-peer reviewed reports
published through Gates, WHO or World Bank websites.
Conference proceedings, protocol papers and any publication for
which sufficient details to determine eligibility cannot be obtained.
Articles written in English Articles written in any language other than English.
Time frame
Articles published in the last 5 years, i.e. 1 January 14–current. Articles published before 1 January 2014.
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currently relevant information and given that systematic
reviews synthesise already published studies, the restric-
tion seems appropriate to minimise more dated informa-
tion. In addition, it is hoped that the restriction on
publication date will minimise the bias associated with
articles being included in more than one review, as re-
peat reviews usually occur less frequently than this. The
5-year restriction is essentially arbitrary but is expected
to be more effective in minimising this type of bias than
say a 10-year period when repeat reviews may be more
common.
Information sources and search methods
A comprehensive search strategy using subject headings
and keywords will be used to search for potentially eli-
gible systematic reviews in four databases: Medline,
Embase, Global Health and Cochrane Systematic Re-
views (from 2014 onwards). A sample search strategy is
included as Additional file 2. The final search strategy
will be developed with advice from information special-
ists by an iterative process, adapted for each database
and peer reviewed to minimise errors.
Additional searches will be conducted on the Gates
Foundation, the World Health Organisation (WHO) and
World Bank websites.
Screening and selection procedure
Records will be stored and managed using reference
management software (Endnote and Zotero).
Titles and abstracts will be screened against the eligi-
bility criteria and full-text articles will be obtained for all
titles that meet the inclusion criteria or where there is
uncertainty around eligibility. Initial screening of all arti-
cles and full-text review of potentially eligible articles
will be conducted by BD. A second reviewer will inde-
pendently screen 20% of all titles and abstracts and 20%
of included full texts. Any discrepancies in the inclusion
of abstracts or full-text articles will be resolved by dis-
cussion and reaching a consensus. In the event a consen-
sus cannot be reached, a third author will arbitrate. Any
inconsistencies in the screening approach of the inde-
pendent screening will be addressed, a strategy to ensure
consistency will be developed and then implemented in
a repeat of the exercise.
Data extraction
A data extraction table will be developed during the re-
view process and will be piloted and refined before full
data extraction commences. The main data to be ex-
tracted will be related to the factors identified as influen-
cing patients’ access to healthcare, e.g. barriers and
facilitators to access. These data will be collected and
categorised according to the three delays model during
data extraction to identify where in the patient pathway
barriers and facilitators to accessing care occur in differ-
ent settings and for different patient groups [9]. Due to
the nature of the research question, it is not possible to
make any assumptions about what these factors will be
without introducing bias into the review and so data will
be extracted as it is presented in the included systematic
review. In addition to the factors affecting access, other
data to be extracted will include: characteristics of the
included reviews such as authors, year of publication,
focus of the study/review question and clinical area, and
features of the study design such as sources searched,
limits, and eligibility criteria; the setting of the study in-
cluding country/ies studied and income classification of
study setting; methods used to identify factors affecting
access to care; and data on included studies such as
number included and types of study, e.g. quantitative or
qualitative. Data on the primary articles included in re-
views will not be collected systematically for all reviews
as it is intended that data will be extracted from the sys-
tematic reviews not the primary articles they refer to.
BD will perform data extraction for all articles included
in the review and a second reviewer will confirm this
data for 20% of included studies. Any discrepancies in
data extraction will be resolved by discussion to reach a
consensus. In the event a consensus cannot be reached,
a third reviewer will arbitrate. Any inconsistencies in
data extraction will be noted and a strategy to ensure
consistency for the remaining data extraction will be
implemented.
Quality assessment and risk of bias
Methodological quality/risk of bias will be assessed for
each included study using the AMSTAR 2 tool [10].
AMSTAR 2 is a comprehensive tool aimed at assessing
the methodological quality of systematic reviews and
also has several dimensions to record assessments of
meta-biases within the review. The quality assessment
will be used to inform the narrative synthesis, but a low-
quality score will not necessarily lead to study exclusion.
BD will conduct the quality assessment for each in-
cluded review, of which 20% will be confirmed by a
second reviewer. Any discrepancies will be resolved
through discussion to reach a consensus and, in the
event a consensus cannot be reached, a third reviewer
will arbitrate. Any inconsistencies in the quality assess-
ment will be noted and a strategy to ensure consistency
for the remaining will be implemented. The results of
the quality appraisal using the AMSTAR 2 tool will be
reported alongside the findings of the overview.
Publication bias within this overview will be assessed
by searching the PROSPERO database for relevant re-
views that have been registered but not published. Al-
though there is no perfect way to assess publication bias
this could give an idea of other relevant research that is
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either ongoing or has been abandoned, and so is not in-
cluded in this review.
Synthesis of results
Extracted data will be tabulated to aid with identification
of commonalities and variations in the factors deemed
important in the included studies. The tabulation will
also aid with the identification of subgroups within the
data. Characteristics of the included studies will be tabu-
lated alongside the factors they identify as affecting ac-
cess to healthcare. This will facilitate discussion of
variations in what factors are important in different
groups of countries based on social, economic and cul-
tural characteristics. Variations in factors affecting access
will be synthesised for subgroups of counties based on,
for example, their income classification, their geograph-
ical location, the type of healthcare system, and cultural
characteristics (subgroups identified will depend on the
available data). Where subgroups are identified, synthesis
will reflect on the commonalities across studies within
the subgroup, and differences as compared with other
studies/subgroups, as appropriate. A descriptive, narra-
tive synthesis will be used to summarise the data from
different studies, framed with reference to the strength
and quality of the evidence. Findings of included reviews
will be narratively described including explanation of
their study characteristics with reference to the clinical
area and study population on which they focus, the
number and type of included study and conclusions
drawn in terms of factors identified as influencing
healthcare access. Influencing factors will be discussed
in relation to the three delays model to examine where
in the patient pathway it is common to find barriers/fa-
cilitators to healthcare access in different settings [9].
Where applicable, these factors will be broken down and
explained as demand-side (patient) factors or supply-
side (healthcare provider) factors. In the event that mul-
tiple studies have identical study setting and study
design/focus but present different findings in terms of
the factors influencing healthcare access, the results will
be synthesised and discussed together as jointly present-
ing factors affecting access for that particular group.
Discussion
While fair access to safe, affordable healthcare is inter-
nationally recognised as key to achieving the global
goals, to date no study has considered factors affecting
access to healthcare through a global lens. This study
aims to address that gap by bringing together evidence
of what factors affect patients’ ability to access health-
care and explore how those factors vary in different
countries/contexts around the world. Factors affecting
patients’ ability to access healthcare will be identified
and analysed according to different country and context
characteristics to shed light on the importance of differ-
ent factors in different settings. The results may guide
future research in this area and contribute to priority
setting for development initiatives aimed at ensuring
equitable access to healthcare for all. Any deviations
from the methods outlined in this protocol will be docu-
mented and justified when results are presented.
There are a number of potential limitations that
should be considered. Due to resource constraints, only
articles published in English will be included in this
overview. This could lead to evidence selection bias as
studies published in other languages will be excluded
from the pool of evidence collected. In addition, only
published research will be eligible for inclusion. While
we recognise this could introduce reporting bias into
our findings, this was necessary to ensure enough infor-
mation was available for data extraction and quality ap-
praisal. Given that our research question is not clinical
in nature, perhaps the risk of reporting bias is reduced
as there is no ‘positive’ or ‘negative’ results as such, and
instead the focus is on the real-life context and processes
associated with receiving healthcare. There are also po-
tential biases and quality issues in individual studies that
feed into the reviews included in this overview. We also
expect there to be a lack of weighting of individual stud-
ies given the likelihood of qualitative and mixed methods
systematic reviews and consequently findings will be
considered equally. A further limitation of this review is
the large amount of relevant research which can cause
difficulties in summarising and interpreting data. We
have addressed this by adopting an overview of reviews
approach to keep the review manageable and by taking a
structured yet pragmatic approach to data extraction
and synthesis. Nevertheless given the heterogeneity of
the studies likely to be included, difficulties with synthe-
sis of data and assessments of bias may remain.
One methodological difficulty in synthesising findings
from overviews of systematic reviews is overlapping sys-
tematic reviews, i.e. if a study is included in more than
one review which is included in the overview [11]. This
problem is brought about by the layers of synthesis in an
overview as compared to a systematic review. For over-
views looking to combine results of systematic reviews
quantitatively (e.g. in meta-analysis of treatment effect),
there is possible bias if included systematic reviews con-
tain the same papers. This can mean some studies are
double counted in the analysis. As this review aims to
synthesise evidence narratively, the effects of this type of
bias are perhaps less significant. In addition, steps were
taken in the design of the study to minimise this bias.
For example, limiting the year of publication to a 5-year
window is likely to minimise the number of repeated re-
views in a particular area or setting. Nevertheless, refer-
ence lists of included studies will be examined to
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identify any studies that are included in multiple reviews.
These will be identified explicitly within the narrative
synthesis and accounted for in the interpretation.
As the focus of this review is to collect and examine
factors (barriers and facilitators) affecting access to
healthcare from existing systematic reviews, the decision
was taken to exclude reviews synthesising evidence
about only one barrier, facilitator or intervention. This
decision was taken as reviews of this type may ignore
other factors that might also be important and may
introduce a bias towards factors that are pre-
determined. However, we recognise that articles of this
type may provide additional insights into factors affect-
ing access to healthcare, how they are perceived and per-
haps more detailed information about select barriers or
facilitators. Consequently, although we will exclude this
type of reviews from the main overview, these records
will be grouped separately to enable additional analysis
to be conducted after the main overview. A data extrac-
tion form will be developed and piloted for this purpose
which will be informed by the main overview. This data
extraction is likely to be more simplified than that for
the main overview and the data will be synthesised
narratively.
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